santa cruz biotechnology, inc.
SCBT Logo

Willkommen!        Produkt(e) im Warenkorb.     Bestellen
 

PLA2 Inhibitors and Controls

  • 7,7-Dimethyleicosadienoic Acid (DEDA)
    DEDA is an arachidonic acid analog that inhibits phospholipase A2 (PLA2). It is reported to inhibit SRS-A biosynthesis occurring in peritoneal cells of rats.
    Katalog #CAS NummerSummenformelMenge
    sc-20070789560-01-0C22H40O210 mg/50 mg
  • AACOCF3
    Shown to be a trifluoromethylketone derivative of arachidonic acid. Reported to directly binding and inhibiting cytosolic human phospholipase A2.
    Katalog #CAS NummerSummenformelMenge
    sc-201412149301-79-1C21H31F3O10 mg/50 mg
  • AACOCH3
    Negative control for AACOCF31,2 but stimulates AA release by way of possible inhibitor of metabolizing or uptake enzymes, or via direct stimulation of PLA21
    Katalog #CAS NummerSummenformelMenge
    sc-205590n.n.C21H34O10 mg/50 mg
  • Aristolochic Acid
    Shown to be an inhibitor of PLA2 and also suppress edema-inducing activity. Also reported as an anti-inflammatory agent.
    Katalog #CAS NummerSummenformelMenge
    sc-200731313-67-7C17H11NO750 mg/250 mg
  • Aristolochic Acid B
    Katalog #CAS NummerSummenformelMenge
    sc-358881475-80-9C16H9NO65 mg
  • Cytidine 5'-diphosphocholine, Sodium Salt (CDP-choline)
    A potent inhibitor of PLA2 with various hormone inducing as well as potential neural and non-neural cholinergic increasing properties.
    Katalog #CAS NummerSummenformelMenge
    sc-20071333818-15-4C14H25N4O11P2 ·Na100 mg/1 g
  • HELSS (Haloenol lactone suicide substrate, BEL, Bromoenol lactone)
    A potent and irreversible inhibitor of calcium-independent phospholipase and cellular cytosolic magnesium-dependent PAP.
    Katalog #CAS NummerSummenformelMenge
    sc-20141888070-98-8C16H13BrO25 mg/25 mg
  • OBAA
    Potent inhibitor of phospholipase A2.
    Katalog #CAS NummerSummenformelMenge
    sc-202748134531-42-3C28H44O35 mg
  • Manoalide
    Manoalide is a potent irreversible inhibitor of phospholipase C and A2. Its mechanism of action involves covalent modification of lysine residues. Also inhibits PLC and calcium channels.
    Katalog #CAS NummerSummenformelMenge
    sc-20073375088-80-1C25H36O51 mg
  • Oleyoxyethyl Phosphorylcholine
    Oleyoxyethyl Phosphorylcholine is used as a potent inhibitor in order to investigate the various biological roles of phospholipase A2 (PLA2).
    Katalog #CAS NummerSummenformelMenge
    sc-20071196720-06-8C25H52NO5P10 mg/50 mg
  • ONO-RS-082
    Shown to be a potent phospholipase A2 inhibitor and block thromboxane production in human platelets stimulated by epinephrine.
    Katalog #CAS NummerSummenformelMenge
    sc-20141099754-06-0C21H22ClNO320 mg/100 mg
  • PACOCF3
    Selective cPLA2 (IC50=45 µM) and iPLA2 inhibitor (IC50=3.8 µM).
    Katalog #CAS NummerSummenformelMenge
    sc-201414141022-99-3C17H31F3O10 mg/50 mg
  • PACOCH3
    The compound is derived from β-ketostearic acid and is an analog of AACOCF3 and PACOCF3. The compound does not block the effects of PLA2 and can be used as a control.
    Katalog #CAS NummerSummenformelMenge
    sc-2014162922-51-2C17H34O10 mg/50 mg
  • Quinacrine, Dihydrochloride
    A non-specific phospholipase A2 (PLA2) inhibitor. Acts as an acetylcholine receptor antagonist. Suppresses glibenclamide-sensitive K+-currents (IC50 = 4.4 µM). Also inhibits monoamine oxidase (MAO).
    Katalog #CAS NummerSummenformelMenge
    sc-20422269-05-6C23H30CIN3O•2HCL100 mg
  • sPLA2 (Type III)
    Isolated from bee venom where one unit of enzyme hydrolyzes one µmol of Diheptanoyl Thio-PC per minute at 25° C.
    Katalog #CAS NummerSummenformelMenge
    sc-2055129001-84-7n.n.1 mg/5 mg
  • Thioetheramide PC
    Thioetheramide-PC is a reversible inhibitor of secretory phospholipase A2 (sPLA2) that binds to both the catalytic site and activator site of sPLA2.
    Katalog #CAS NummerSummenformelMenge
    sc-202840116457-99-9C40H83N2O5PS5 mg/25 mg
  • sPLA2 inhibitor
    Orally active, potent secretory Phospholipase A2 (sPLA2; Group IIa) inhibitor.
    Katalog #CAS NummerSummenformelMenge
    sc-215901393569-31-8C31H37NO45 mg/25 mg
  • YM 26734
    A competitive inhibitor of several isoforms of secretory PLA2 (sPLA2) that has been shown to negligibly effect sPLA2-IIF and cytosolic PLA2.
    Katalog #CAS NummerSummenformelMenge
    sc-204410144337-18-8C45H62O810 mg